HLA-A*0201 Positive Cells Present research hub

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

This study is testing a new drug called tebentafusp for advanced clear cell sarcoma. It's for patients whose cancer cells have a specific marker called HLA-A*02:01. We want to see if the drug can help shrink the tumour or stop it from growing.